These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2518861)

  • 1. Nature and time-course of piroxicam-induced injury to human gastric mucosa.
    Fellows IW; Bhaskar NK; Hawkey CJ
    Aliment Pharmacol Ther; 1989 Oct; 3(5):481-8. PubMed ID: 2518861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastrointestinal tolerability of meloxicam and piroxicam: a double-blind placebo-controlled study.
    Lipscomb GR; Wallis N; Armstrong G; Rees WD
    Br J Clin Pharmacol; 1998 Aug; 46(2):133-7. PubMed ID: 9723821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastroduodenal lesions associated with two different piroxicam formulations. An endoscopic comparison.
    Aabakken L; Olaussen B; Mowinckel P; Osnes M
    Scand J Gastroenterol; 1992 Dec; 27(12):1049-54. PubMed ID: 1475622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of faecal blood loss, upper gastrointestinal mucosal integrity and symptoms after piroxicam beta-cyclodextrin, piroxicam and placebo administration.
    Patoia L; Clausi G; Farroni F; Alberti P; Fugiani P; Bufalino L
    Eur J Clin Pharmacol; 1989; 36(6):599-604. PubMed ID: 2673795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Piroxicam-beta-cyclodextrin: effects on gastrointestinal blood loss and gastric mucosal appearance in healthy men.
    Warrington S; Debbas N; Farthing M; Horton M; Umile A
    Int J Tissue React; 1991; 13(5):243-8. PubMed ID: 1806546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastric damage induced by subchronic administration of preferential cyclooxygenase-1 and cyclooxygenase-2 inhibitors in rats.
    Villegas I; Alarcón de la Lastra C; Martín MJ; Motilva V; La Casa García C
    Pharmacology; 2002 Oct; 66(2):68-75. PubMed ID: 12207113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Protective effect of ranitidine in the stomach and duodenum against piroxicam. An endoscopy controlled double-blind study].
    Müller P; Simon B
    Arzneimittelforschung; 1992 Dec; 42(12):1492-4. PubMed ID: 1288514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Placebo-controlled comparison of piroxicam-beta-cyclodextrin, piroxicam, and indomethacin on gastric potential difference and mucosal injury in humans.
    Santucci L; Fiorucci S; Chiucchiù S; Sicilia A; Bufalino L; Morelli A
    Dig Dis Sci; 1992 Dec; 37(12):1825-32. PubMed ID: 1473431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effective prevention of piroxicam-induced lesions of the gastric mucosa with nizatidine].
    Dammann HG; Simon-Schultz J; Dreyer M; Simon B; Müller P
    Z Gastroenterol; 1990 Feb; 28(2):94-6. PubMed ID: 1969684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The acute action of fenbufen and piroxicam on the gastric mucosa as measured by gastric microbleeding.
    Collins AJ; Notarianni LJ
    J Int Med Res; 1984; 12(3):179-83. PubMed ID: 6610580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastric mucosal blood flow and neutrophil activation in aspirin-induced gastric mucosal damage in man.
    Konturek JW; Dembinski A; Stoll R; Konturek M; Domschke W
    Scand J Gastroenterol; 1993 Sep; 28(9):767-71. PubMed ID: 8235431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ranitidine: differential effects on gastric bleeding and mucosal damage induced by aspirin.
    Cole AT; Brundell S; Hudson N; Hawthorne AB; Mahida YR; Hawkey CJ
    Aliment Pharmacol Ther; 1992 Dec; 6(6):707-15. PubMed ID: 1486156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of piroxicam-beta-cyclodextrin on the gastrointestinal tract.
    Warrington S
    Eur J Rheumatol Inflamm; 1993; 12(4):29-37. PubMed ID: 7805701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of microbleeding and an ultrathin endoscope to assess gastric mucosal protection by famotidine.
    Daneshmend TK; Prichard PJ; Bhaskar NK; Millns PJ; Hawkey CJ
    Gastroenterology; 1989 Oct; 97(4):944-9. PubMed ID: 2570732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucosal damage induced by preferential COX-1 and COX-2 inhibitors: role of prostaglandins and inflammatory response.
    Villegas I; La Casa C; de la Lastra CA; Motilva V; Herrerías JM; Martín MJ
    Life Sci; 2004 Jan; 74(7):873-84. PubMed ID: 14659976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human gastric mucosal bleeding induced by low dose aspirin, but not warfarin.
    Prichard PJ; Kitchingman GK; Walt RP; Daneshmend TK; Hawkey CJ
    BMJ; 1989 Feb; 298(6672):493-6. PubMed ID: 2495079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Endoscopic, histologic and morphometric evaluation of the gastric mucosa in patients with osteoarthritis treated with piroxicam and zinc acexamate].
    Guilarte López-Mañas J; Valenzuela Barranco M; Caballero Plasencia AM; Martín Ruiz JL
    Gastroenterol Hepatol; 1998 May; 21(5):212-7. PubMed ID: 9644873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Helicobacter pylori and gastric adaptation to repeated aspirin administration in humans.
    Konturek JW; Dembiński A; Konturek SJ; Domschke W
    J Physiol Pharmacol; 1997 Sep; 48(3):383-91. PubMed ID: 9376621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of endoscopic gastric mucosa features after administration of piroxicam to meloxicam and their correlation with dyspepsia symptoms in elderly patient with knee osteoarthritis.
    Girawan D; Abdurachman SA; Djumhana A; Roslia J; Pramudiyo R
    Acta Med Indones; 2004; 36(4):202-6. PubMed ID: 15673949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of early vascular damage in the pathogenesis of gastric haemorrhagic mucosal lesions induced by indomethacin in rats.
    Gyömber E; Vattay P; Szabo S; Rainsford KD
    Int J Exp Pathol; 1996 Feb; 77(1):1-6. PubMed ID: 8664141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.